SSI NEW MATERIAL: Hong Kong Main Board IPO Application Lapsed, Ranking No.1 in Global Acoustic Enhancement Materials Market
NewTimeSpace News: Information published on the HKEX website shows that the Hong Kong Main Board listing application submitted by SSI New Material (Zhenjiang) Co., Ltd. on 12 January 2026 has recently lapsed after the six-month validity period expired. Guotai Junan International served as the sole sponsor upon submission.
SSI New Material is an electronic functional enhancement materials enterprise with established market positioning across acoustic enhancement materials, electronic ceramic materials, electronic adhesives and energy enhancement materials. According to Frost & Sullivan statistics, based on revenue generated in the first half of 2025:It ranks No.1 in the global acoustic enhancement materials market with a market share of 18.1%;It ranks No.2 in the global alumina ceramic materials market for lithium-ion battery separator coating, with a market share of approximately 18.1%;It ranks No.4 in the global acoustic adhesives market, with a market share of around 3.5%;It ranks No.3 in the global high-reflective glaze market, holding a 5.0% market share.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- SSI NEW MATERIAL Secures CSRC Filing Approval, Plans Issuance of Approximately 103.50 Million H-shares with Full Tradability
- ZHAOKE OPHTH-B (06622.HK): Acquires Global Rights to NVK002 (Atropine Sulfate Eye Drops) to Fully Control Paediatric Myopia Programme Development
- MODERN LAND (01107.HK): Receives HKEX Resumption Guidance, Required to Publish Outstanding Results & Demonstrate Effective Internal Controls; Shares Remain Suspended
- LEADS BIOLABS-B (09887.HK): Six Research Abstracts Accepted for ESMO Congress 2026, Including Two Proffered Paper Presentations and LBA Eligibility